Schwenzer K J, Gist A, Durbin C G
Department of Anesthesiology and Surgery, University of Virginia Health Sciences Center, Charlottesville 22908.
Intensive Care Med. 1994 Jul;20(6):425-30. doi: 10.1007/BF01710653.
To determine which clinical features are associated with bacteremia in a SICU. To determine if infections are identified prior to bacteremia via culturing of other body fluids. To determine if antibiotic regimens are changed after the results of the blood culture were obtained.
A retrospective, unit-based, case control study.
A 10 bed SICU in a 552-bed, tertiary care and Level I Trauma center.
All SICU patients with one or more positive blood cultures over a 2 year period (n = 24) were matched by diagnosis, procedure, and age to SICU patients with negative blood cultures (n = 48).
Bacteremic and control patients had similar APACHE II scores though death was more likely in bacteremic patients (p < 0.05) and they had higher hospital charges (p < 0.02). There was no difference in any of the clinical variables studied (minimum and maximum temperature, maximum white blood cell count, minimum mean arterial blood pressure) between the bacteremic and control groups on the days leading up to and the day of the positive blood culture. Coincident infections of lung, bladder, wound, and central venous catheters were identified in 42% of bacteremic patients. The identification of organisms found in the blood had a direct impact on the antibiotic regimen of 54% of the bacteremic patients.
A better screen for obtaining blood cultures in this SICU was not identified. If antibiotics are begun empirically before the results of blood cultures are known, the results of other body fluid cultures can be used to guide therapy initially. However, the data obtained from positive blood cultures was often helpful in changing empirical therapy. Therefore, blood cultures remain important diagnostic tools.
确定外科重症监护病房(SICU)中哪些临床特征与菌血症相关。确定是否通过其他体液培养在菌血症发生前识别出感染。确定在获得血培养结果后抗生素治疗方案是否改变。
一项基于病房的回顾性病例对照研究。
一家拥有552张床位的三级医疗和一级创伤中心内的10张床位的SICU。
在两年期间所有血培养结果为一项或多项阳性的SICU患者(n = 24),按照诊断、手术和年龄与血培养结果为阴性的SICU患者(n = 48)进行匹配。
菌血症患者和对照患者的急性生理与慢性健康状况评分系统(APACHE II)得分相似,不过菌血症患者死亡可能性更高(p < 0.05),且住院费用更高(p < 0.02)。在血培养阳性前几天及阳性当天,菌血症组和对照组在任何研究的临床变量(最低和最高体温、最高白细胞计数、最低平均动脉血压)方面均无差异。42%的菌血症患者同时存在肺部、膀胱、伤口和中心静脉导管感染。血中发现的病原体鉴定对54%的菌血症患者的抗生素治疗方案有直接影响。
未找到在该SICU中更好的获取血培养的筛查方法。如果在血培养结果未知前经验性使用抗生素,其他体液培养结果可最初用于指导治疗。然而,从阳性血培养获得的数据通常有助于改变经验性治疗。因此,血培养仍然是重要的诊断工具。